Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cefuroxime Acid Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109988183B details an eco-friendly route for cefuroxime acid intermediate DCC, eliminating DMAC and reducing waste for reliable supply.
Patent CN109988183A reveals a green synthesis route for DCC using triphosgene, eliminating DMAC solvent for reduced cost and higher purity in pharmaceutical manufacturing.